Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)

BACKGROUND: Primary inflammatory breast cancer (IBC) is a rare and aggressive entity whose prognosis has been improved by multimodal therapy. However, 5-year overall survival (OS) remains poor. Given its low incidence, the prognosis of IBC at metastatic stage is poorly described. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Dano, D., Lardy-Cleaud, A., Monneur, A., Quenel-Tueux, N., Levy, C., Mouret-Reynier, M.-A., Coudert, B., Mailliez, A., Ferrero, J.-M., Guiu, S., Campone, M., de La Motte Rouge, T., Petit, T., Pistilli, B., Dalenc, F., Simon, G., Lerebours, F., Chabaud, S., Bertucci, F., Gonçalves, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327489/
https://www.ncbi.nlm.nih.gov/pubmed/34303929
http://dx.doi.org/10.1016/j.esmoop.2021.100220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327489/
https://www.ncbi.nlm.nih.gov/pubmed/34303929
http://dx.doi.org/10.1016/j.esmoop.2021.100220

Ejemplares similares